A novel series of matrix metalloproteinase inhibitors for the treatment of inflammatory disorders
- 1 January 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (7) , 897-902
- https://doi.org/10.1016/s0960-894x(97)00125-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Recent advances in matrix metalloproteinase inhibitor researchDrug Discovery Today, 1996
- Review Oncologic, Endocrine & Metabolic: Recent developments in matrix metalloproteinase inhibitorsExpert Opinion on Therapeutic Patents, 1995
- Proteinases and inhibitorsBritish Medical Bulletin, 1995
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee InjuryArthritis & Rheumatism, 1992
- The origin of matrix metalloproteinases and their familial relationshipsFEBS Letters, 1991
- The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritisArthritis & Rheumatism, 1990
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989
- Collagenase Inhibitors: Their Design and Potential Therapeutic UseJournal of Enzyme Inhibition, 1987
- Metal binding peptide inhibitors of vertebrate collagenaseBiochemical and Biophysical Research Communications, 1981